GlassScriptPhysician profile
Joe D Mobley
NPI 1316931462
$9,868.49
in general payments reported to CMS, 2019-2025
27 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $1,371 · 2021: $1,342 · 2022: $4,376 · 2023: $425 · 2024: $301 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,910.27 | 2019-2025 | Spaceoar Vue System - 10ml, Solyx Sis System, Lithovue Elite |
| Axonics, INC. | $2,336.41 | 2020-2022 | |
| Caldera Medical, INC | $1,127.24 | 2020-2025 | Desara |
| Olympus America INC. | $908.21 | 2022-2025 | Itind System |
| Teleflex LLC | $657.14 | 2022-2025 | Urolift |
| Dendreon Pharmaceuticals LLC | $297.50 | 2019-2020 | |
| Coloplast Corp | $287.38 | 2019-2024 | |
| Angiodynamics, INC. | $168.86 | 2021-2025 | Nanoknife |
| Endo USA, INC. | $137.16 | 2025 | Xiaflex |
| Procept Biorobotics Corporation | $136.34 | 2025 | |
| Photocure INC | $114.35 | 2021-2024 | Cysview |
| Urovant Sciences INC | $110.45 | 2021-2022 | |
| Immunitybio, INC. | $80.30 | 2025 | |
| Bard Access Systems, INC. | $77.25 | 2019 | |
| Sumitomo Pharma America, INC. | $70.76 | 2023 | Gemtesa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $70.68 | 2021-2024 | |
| Medtronic USA, INC. | $70.45 | 2019-2020 | |
| Medtronic, INC. | $61.78 | 2022-2023 | Interstim |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Fujifilm New Development USA, INC. | $33.75 | 2019 | |
| Blue Earth Diagnostics | $31.96 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $25.33 | 2019-2020 | |
| Calyxo, INC. | $24.43 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $22.65 | 2021 | |
| Endo Pharmaceuticals INC. | $21.62 | 2020 | |
| Allergan, INC. | $19.36 | 2020 | |
| Laborie Medical Technologies Corp. | $16.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Mobley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.